Related Experiment Video
Updated: Jul 27, 2025

Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Mycophenolate Mofetil-Induced Colonic Injury Manifesting Endoscopically As Ischemic Colitis
Clive J Miranda1, Murad H Ali1, Muddasir Ayaz2
1Internal Medicine, University at Buffalo, Buffalo, USA.
Mycophenolate mofetil (MMOF), an immunosuppressant, can cause colitis mimicking ischemic colitis in kidney transplant patients. Recognizing these rare endoscopic findings is crucial for accurate diagnosis and management.
Area of Science:
- Gastroenterology
- Transplant Medicine
- Pharmacology
Background:
- Mycophenolate mofetil (MMOF) is a vital immunosuppressant for kidney transplant recipients.
- Diarrhea is a frequent side effect, often prompting endoscopic evaluation.
- MMOF-induced colitis can present with diffuse ulcers and colitis changes.
Observation:
- This case report details an adult male kidney transplant recipient with histopathologically confirmed MMOF-induced colitis.
- The patient exhibited gross endoscopic findings suggestive of ischemic colitis.
- This presentation is an unusual manifestation of MMOF toxicity.
Findings:
- MMOF-induced colitis can rarely present with endoscopic features mimicking ischemic colitis.
- Histopathology confirmed the diagnosis of MMOF-induced colitis.
- The case underscores the spectrum of gastrointestinal side effects associated with MMOF.
Implications:
- Gastroenterologists must consider MMOF-induced colitis in transplant patients with unexplained colitis, even with ischemic-like endoscopic findings.
- Awareness of these rare presentations can prevent misdiagnosis and guide appropriate treatment adjustments.
- This highlights the importance of correlating endoscopic findings with patient medication history and histopathology.
More Related Videos
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
09:42Murine Endoscopy for In Vivo Multimodal Imaging of Carcinogenesis and Assessment of Intestinal Wound Healing and Inflammation
Published on: August 26, 2014
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...